Learning Objectives, March 2009

Printer-friendly version
Source: 
TCPR, March 2009, Vol 7, Issue 3, Antipsychotic Roundup 2009
Learning Objectives
Learning Objective NumberLearning Objective
Learning Objective Number: 
1
Learning Objective: 

Evaluate the evidence supporting the use of atypical antipsychotics for nonpsychotic disorders.

Learning Objective Number: 
2
Learning Objective: 

Describe the major health risks of atypical antipsychotics.

Learning Objective Number: 
3
Learning Objective: 

Outline current concepts in the neurobiology of schizophrenia.

This CME/CE activity is intended for psychiatrists, psychiatric nurses, psychologists and other health care professionals with an interest in the diagnosis and treatment of psychiatric disorders.